Status:
RECRUITING
Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
Ministry of Health and Welfare, Taiwan
Conditions:
Gastric Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Gastric cancer ranks among the top ten leading causes of death in Taiwan. Radical surgery is the sole curative method for gastric cancer. However, our previous research has revealed that elderly gastr...
Eligibility Criteria
Inclusion
- Patients aged sixty-five or older with locally advanced (stage II and stage III) gastric cancer, preparing for curative gastric cancer surgery and scheduled to receive adjuvant chemotherapy within 4-8 weeks postoperatively, either as outpatients or inpatients.
- Patients must provide signed informed consent.
- Estimated survival of more than 3 months.
- Conscious and able to communicate verbally or in writing, and willing to cooperate with invasive procedures.
Exclusion
- Patients with cognitive impairment or unable to cooperate with the interventional procedures as determined by the clinical physician.
- Patients receiving concurrent other anticancer treatments (radiation or surgery).
- Patients with multiple types of cancer requiring simultaneous treatment.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06055387
Start Date
January 1 2022
End Date
December 31 2025
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, Taiwan, 330